Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1280
https://www.valueinhealthjournal.com/article/S1098-3015(13)03185-9/fulltext
Title :
Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03185-9&doi=10.1016/j.jval.2013.08.1280
First page :
A526
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1134